Asia-Pacific Neurosurgery Market, By Product Type (Neurosurgery Devices, Neurosurgery Software, Consumables), Application (Aneurysms, Arteriovenous Malformation (AVM), Brain Tumors, Carotid Artery Blockage/Stenosis, Cerebrovascular Surgery, Cortical Mapping, Epilepsy, Functional Neurosurgery, Intraoperative Angiography, Parkinson's Disease and Tremors, Peripheral Nerve Surgery, Pituitary Tumors, Radiosurgery, Skull Base Surgery, Spine Surgery, Stereotactic Neurosurgery, Trauma Surgery, Trigeminal Neuralgia, Others), Age Group (Pediatric, Adult, Geriatric), End User (Hospitals, Neurosurgery Centers, Research Centers, Ambulatory Surgical Centers, Others), Distribution Channel (Direct Tender, Third Party Distributors, Others) Industry Trends and Forecast to 2029
Asia-Pacific Neurosurgery Market Analysis and Insights
Technological innovation within healthcare may be defined as the introduction of a new technology that initiates a change in clinical practice. Neurosurgery is a particularly technologically intensive surgical discipline, and new technologies have preceded many of the major advances in operative neurosurgical techniques. The present focus is on developing minimally-invasive devices that could decrease the probability of complications during operative sessions. With the introduction of minimally-invasive techniques, doctors are using highly specialized surgical instruments such as power tools, neurovascular embolization devices, and radiosurgery systems such as gamma-knife.
In addition, a set of new factors, such as enhanced regulatory standards and an increasing incidence of neurological diseases, has led to an increase in the adoption of advanced treatment protocols and the assumption that such therapies will be available more widely. This has increased industry and government demand for zero deviations, which has driven the demand for neurosurgical services. An increase in cross-industry alliances and collaborations is a major factor expected to boost the neurosurgery market. However, the higher costs involved in neuro endoscopy equipment and procedures, along with the lack of trained professionals, may restrain the market growth in the forecast period.
Data Bridge Market Research analyzes that the Asia-Pacific neurosurgery market is expected to reach a value of USD 3,535.44 million by 2029, at a CAGR of 15.7% during the forecast period. "Product type" accounts for the largest type segment in the market due to the increasing patient population in the Asia-Pacific region. This market report also covers pricing analysis, patent analysis, and technological advancements in depth.
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2019 - 2015)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Product Type (Neurosurgery Devices, Neurosurgery Software, Consumables), Application (Aneurysms, Arteriovenous Malformation (AVM), Brain Tumors, Carotid Artery Blockage/Stenosis, Cerebrovascular Surgery, Cortical Mapping, Epilepsy, Functional Neurosurgery, Intraoperative Angiography, Parkinson's Disease and Tremors, Peripheral Nerve Surgery, Pituitary Tumors, Radiosurgery, Skull Base Surgery, Spine Surgery, Stereotactic Neurosurgery, Trauma Surgery, Trigeminal Neuralgia, Others), Age Group (Pediatric, Adult, Geriatric), End User (Hospitals, Neurosurgery Centers, Research Centers, Ambulatory Surgical Centers, Others), Distribution Channel (Direct Tender, Third Party Distributors, Others)
|
|
Countries Covered
|
China, Japan, India, South Korea, Singapore, Thailand, Malaysia, Australia, Philippines, Indonesia, and the rest of the Asia-Pacific
|
|
Market Players Covered
|
Medtronic, Abbott, Boston Scientific Corporation, Elekta, ALEVA NEUROTHERAPEUTICS, Machida Endoscope Co., Ltd., Brainlab AG, adeor medical AG, LivaNova PLC, B. Braun SE, Optofine Instruments Pvt. Ltd., Wallaby Medical, Terumo Medical Corporation, NEVRO CORP., Integra LifeSciences, Stryker, Penumbra, Inc., KARL STORZ SE & Co. KG, Renishaw plc, Inomed Medizintechnik GmbH, ANT Neuro, and Leica Microsystems among others
|
Asia-Pacific Neurosurgery Market Definition
The neurological conditions include dementia, headache disorders, neuro-infections, and multiple sclerosis, traumatic brain injuries, pain associated with neurological disorders, neurological disorders associated with malnutrition, stroke, epilepsy, and Parkinson's disease. These disorders are fatal and cannot be cured by therapeutics. Some of the neurosurgery devices are neuro-endoscopes, stereotactic systems, catheters, pacemakers, single- and dual-chamber defibrillators, and implantable cardioverter defibrillators among others, that are used in a variety of neurosurgical procedures. Neurosurgery aids in the diagnosis of patients who have brain tumors, spinal cord injuries brought by accidents, neck and back discomfort, and abnormal spinal fluid movement. Around 7 to 10 million people worldwide suffer from Parkinson's disease. Neurological illness is one of the main causes of morbidity and disability worldwide. During the forecast period, technological developments in neurosurgery are anticipated to drive the market. The rise in incidences and prevalence of neurological conditions within the population and the advantage of neurosurgery over other conventional surgeries are expected to boost the growth of the neurosurgery market across the globe. In addition, advances in neurological surgeries such as 3-dimension reconstruction for brain tumor surgery, X-knife radiosurgery for brain lesions, MRI for brain tumors, and surgery under local anesthesia for brain tumors are anticipated to provide lucrative opportunities for the growth of the neurosurgery market.
Asia-Pacific Neurosurgery Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
- Technological advancement in neurosurgery
Since the beginning of modern neurosurgery, technological advancements have paved the way for a more thorough and enhanced understanding of cerebral form and function to more effectively treat complex pathologies affecting patients. Technological advancements brought a transition from conventional equipment toward energy-efficient equipment based on novel technology. Several cutting-edge techniques help neurosurgeries quite easily. Neurosurgery is a particularly technologically intensive surgical discipline, and new technologies have preceded many of the major advances in operative neurosurgical techniques. Image guidance and neuromodulation devices demonstrated a highly correlated rapid rise in patents and publications, suggesting they are areas of technology expansion which is expected to boost the market growth.
With the growth in the prevalence of neurological conditions, the demand for neurosurgery is also increasing. The market is expected to grow in the forecast period.
Moreover, the adoption of endoscopic techniques' is a significant market advancement. Additionally, recovery time is shorter in neurosurgeries. Thus, all these factors are expected to act as drivers for market growth.
- Rising Prevalence of Neurological Conditions
The World Health Organization (WHO) focuses on research in areas that are important for public health promotion. Recently, WHO has been particularly interested in frequent and disabling neurological disorders with a high burden on the world. Neurological disorders occur among all age groups and different geographical regions. They significantly contribute to morbidity and mortality around the world. The neurological burden of disease is expected to grow exponentially in low- and middle-income countries (LMICs) in the next decade.
The rising prevalence of neurological conditions such as transnasal hemorrhage, intracerebral hemorrhage (ICH), traumatic brain injury, chronic pain, depression, and Parkinson's is expected to drive market growth.
Thus, increasing neurological disorders such as transnasal hemorrhage and intracerebral hemorrhage (ICH) are fueling market growth. Neurological conditions have become a major public health crisis which is expected to boost the growth of the Asia-Pacific neurosurgery market.
Restraint
- The high cost associated with neurosurgeries and equipment
A significant increase in the cost of neurosurgical products has been observed in recent years, which end users such as hospitals and neurosurgical centers have to incur. Products such as neurovascular embolization devices, neurovascular coiling devices, and neuroendoscopes are quite costly. Manufacturers are also giving more resources to research and development to introduce cost-effective and advanced technology. Some complex neurosurgeries require extensive time as well as effort, and they are also quite risky. These complex procedures need advanced techniques and skills, and because of this, the cost of equipment and neurosurgeries increases. The maintenance of such facilities and continuous requirement of power supply add up to the cost of the surgeries. Decompressive craniectomy for traumatic brain injury (TBI) is an expensive procedure that is also associated with high morbidity and mortality.
The cost associated with neurosurgery procedures is quite high, which is expected to act as a restrain for the market growth.
Opportunity
-
Rising awareness about neurological disorders
With the rising Asia-Pacific population, a large portion of the geriatric section is getting affected with neurological disorders such as epilepsy, Parkinson's disease, stroke, brain tumor, dementia, and multiple sclerosis, among others. So, understanding neurological disorders is important, and awareness about neurological conditions can lead to seeking medical attention, which results in proper diagnosis and effective treatment. All neurological disorders account for 82.8%. The massive fold increases the burden of neurological disorders that can be attributed to a lack of awareness about neurological disorders and treatment, which lead to delayed detection, and lack of access to quality healthcare and rehabilitation centers. Rising healthcare programs and increasing funding from governments and public healthcare agencies help reduce the burden of neurological disorders and develop neurological products that act in favor of market growth.
Rising awareness about neurological disorders is beneficial for the neurosurgery market. In most regions, many governmental and non-governmental are carry some awareness programs for the early detection of neurological conditions.
Challenge
- Alternative Treatments For Neurological Disease
Drug therapies are the first line of treatment for the treatment of neurological conditions. Neurosurgical procedures are opted only if non-surgical treatments are not effective. Complementary and alternative treatments are increasingly employed to supplement neurosurgical treatment in neurosurgery. This includes acupuncture, naturopathic medicine, chiropractic treatment, and ayurvedic medicine among others. More recently, doctors have become increasingly receptive to the use of alternative treatments, and scientific studies on the safety and effectiveness of complementary and alternative options are taken through the national institutes of health, which may act as a challenge to the growth of the neurosurgery market.
Thus, alternative treatment options are expected to offer significant challenges for the Asia-Pacific neurosurgical market.
Post-COVID-19 Impact on Asia-Pacific Neurosurgery Market
The COVID-19 outbreak had a drastic effect on Asia-Pacific healthcare, with China amongst the countries most severely impacted. The pandemic has had a negative impact on the neurosurgery market growth on account of the temporary halt in research activities in this field, coupled with the low influx of patients in hospitals and diagnostic centers. Moreover, the impact of COVID-19 pandemic on neurosurgical products delivery is challenging the neurosurgeons for getting delivery of surgical products.
Manufacturers are making various strategic decisions to bounce back post-COVID-19. The players are conducting multiple R&D activities and product launches, and strategic partnerships to improve the technology in the neurosurgery market.
Recent Developments
- In March 2022, Medtronic, an Asia-Pacific leader in healthcare technology, announced their first patient implants in the TITAN 2 pivotal study that evaluated the safety and efficacy of Medtronic's investigational implantable tibial neuromodulation (TNM) device in people with overactive bladder (OAB). Implantable TNM has the potential to give relief to millions who suffer from bladder incontinence through a new approach that provides greater convenience and more options for physicians and patients. This will help the company to evaluate the safety and efficacy of its products
- In April 2022, Abbott announced that it had launched an upgraded version of its NeuroSphere myPath digital health app with enhanced functionality that will help doctors more closely track their patients as they trial Abbott neurostimulation devices to address their chronic pain. This upgrade is part of Abbott's commitment to connected care technology and is intended to put people in control of their health and facilitate better communication with their doctors. This has helped the company to enhance its product use by launching the app
Asia-Pacific Neurosurgery Market Scope
The neurosurgery market is segmented into product type, application, age group, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
By Product Type
- Neurosurgery devices
- Neurosurgery software
- Consumables
On the basis of product type, the neurosurgery market is segmented into neurosurgery devices, neurosurgery software, and consumables.
By Application
- Aneurysms
- Arteriovenous malformation (AVM)
- Brain tumors
- Carotid artery blockage/stenosis
- Cerebrovascular surgery
- Cortical mapping
- Epilepsy
- Functional neurosurgery
- Intraoperative angiography
- Parkinson's disease and tremors
- Peripheral nerve surgery
- Pituitary tumors
- Radiosurgery
- Skull base surgery
- Spine surgery
- Stereotactic neurosurgery
- Trauma surgery
- Trigeminal neuralgia
- Others
On the basis of application, the neurosurgery market is segmented into aneurysms, arteriovenous malformation (AVM), brain tumors, carotid artery blockage/stenosis, cerebrovascular surgery, cortical mapping, epilepsy, functional neurosurgery, intraoperative angiography, Parkinson's disease and tremors, peripheral nerve surgery, pituitary tumors, radiosurgery, skull base surgery, spine surgery, stereotactic neurosurgery, trauma surgery, trigeminal neuralgia, others.
By Age Group
- Pediatric
- Adult
- Geriatric
On the basis of end user, the neurosurgery market is segmented into pediatric, adult, and geriatric.
By End User
- Hospitals
- Research centers
- Neurosurgery centers
- Ambulatory surgical centers (ASCS)
- Others
On the basis of end user, the neurosurgery market is segmented into hospitals, neurosurgery centers, research centers, ambulatory surgical centers, and others
By Distribution Channel
- Direct tender
- Third party distributors
- Others
On the basis of distribution channel, the Asia-Pacific neurosurgery market is segmented into direct tender, third party distributors, and others
Asia-Pacific Neurosurgery Market Regional Analysis/Insights
The Asia-Pacific neurosurgery market is analyzed, and market size information is provided by product type, application, age group, end user, and distribution channel.
The countries covered in this market report are China, Japan, India, South Korea, Singapore, Thailand, Malaysia, Australia, Philippines, Indonesia, and the rest of Asia-Pacific.
In 2022, Asia-Pacific is expected to be the third most dominating region due to the increasing healthcare expenditure. China is expected to dominate the Asia-Pacific neurosurgery market and grow due to the rise in technological advancement in neurosurgical equipment.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, and the impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Asia-Pacific Neurosurgery Market Share Analysis
Asia-Pacific neurosurgery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company's focus on the Asia-Pacific neurosurgery market.
Some of the major players operating in the Asia-Pacific neurosurgery market are Medtronic, Abbott, Boston Scientific Corporation, Elekta, ALEVA NEUROTHERAPEUTICS, Machida Endoscope Co., Ltd., Brainlab AG, adeor medical AG, LivaNova PLC, B. Braun SE, Optofine Instruments Pvt. Ltd., Wallaby Medical, Terumo Medical Corporation, NEVRO CORP., Integra LifeSciences, Stryker, Penumbra, Inc., KARL STORZ SE & Co. KG, Renishaw plc, Inomed Medizintechnik GmbH, ANT Neuro, and Leica Microsystems among others.
Research Methodology: Asia-Pacific Neurosurgery Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by the DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Asia-Pacific vs Regional, and Vendor Share Analysis. Please request an analyst call in case of further inquiry.
SKU-